Vessel size imaging using dual contrast agent injections
暂无分享,去创建一个
Yuan-Yu Hsu | Kun-Eng Lim | Ho-Ling Liu | Y. Hsu | Ho-Ling Liu | K. Lim | Wei-Shan Yang | Wei-Shan Yang
[1] Z. Rumboldt,et al. Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors , 2006, Neuroradiology.
[2] M. Décorps,et al. Vessel size imaging , 2001, Magnetic resonance in medicine.
[3] L. Østergaard,et al. Comparison of gradient‐ and spin‐echo imaging: CBF, CBV, and MTT measurements by bolus tracking , 2000, Journal of magnetic resonance imaging : JMRI.
[4] L. D.,et al. Brain tumors , 2005, Psychiatric Quarterly.
[5] R. Strecker,et al. Vessel size imaging in humans , 2005, Magnetic resonance in medicine.
[6] M. McDermott,et al. Perfusion MR imaging of an intracranial collision tumor confirmed by image-guided biopsy. , 2006, AJNR. American journal of neuroradiology.
[7] B. D. Ward,et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.
[8] I. Nöbauer-Huhmann,et al. The optimal use of contrast agents at high field MRI , 2006, European Radiology.
[9] M. Preul. The Human Brain: Surface, Blood Supply, and Three-Dimensional Sectional Anatomy , 2001 .
[10] Susan M. Chang,et al. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. , 2005, AJNR. American journal of neuroradiology.
[11] Y Usson,et al. In vivo assessment of tumoral angiogenesis , 2004, Magnetic resonance in medicine.
[12] R. Chandra,et al. MR imaging of microvasculature , 2000, Magnetic resonance in medicine.
[13] J. A. van der Laak,et al. Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. , 1998, Human pathology.
[14] H. Duvernoy. The Human Brain , 1999, Springer Vienna.
[15] R Weissleder,et al. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.
[16] B R Rosen,et al. Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.
[17] S. Posse,et al. Analytical model of susceptibility‐induced MR signal dephasing: Effect of diffusion in a microvascular network , 1999, Magnetic resonance in medicine.
[18] A P Pathak,et al. Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.
[19] H. Duvernoy. Blood supply of the cerebral cortex , 1999 .
[20] K. Schmainda,et al. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. , 2008, Radiology.
[21] Matilde Inglese,et al. Microvessel density estimation in the human brain by means of dynamic contrast‐enhanced echo‐planar imaging , 2006, Magnetic resonance in medicine.
[22] Tristan Barrett,et al. MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.
[23] Richard Frayne,et al. Improved dynamic susceptibility contrast (DSC)‐MR perfusion estimates by motion correction , 2007, Journal of magnetic resonance imaging : JMRI.
[24] A. Berenstein,et al. Dural and Bony Tumors , 2004 .
[25] Hans H Schild,et al. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. , 2005, Radiology.
[26] Glyn Johnson,et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.
[27] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.
[28] G Johnson,et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. , 2007, AJNR. American journal of neuroradiology.